QNCX – quince therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Quince Therapeutics Engages LifeSci Capital as its Exclusive Financial Advisor to Explore Strategic Alternatives
Quince Therapeutics (NASDAQ:QNCX) was downgraded by analysts at Maxim Group from a "strong-buy" rating to a "hold" rating.
Quince Therapeutics (NASDAQ:QNCX) was downgraded by analysts at Brookline Capital Management from a "strong-buy" rating to a "hold" rating.
Quince Therapeutics (NASDAQ:QNCX) was downgraded by analysts at D Boral Capital from a "strong-buy" rating to a "hold" rating.
Quince Therapeutics (NASDAQ:QNCX) was downgraded by analysts at Lucid Cap Mkts from a "strong-buy" rating to a "strong sell" rating.
Form 8-K Quince Therapeutics, For: Jan 30
Form 8-K Quince Therapeutics, For: Jan 29
Form 4 Quince Therapeutics, For: Jan 23 Filed by: Thye Dirk
Form 4 Quince Therapeutics, For: Jan 23 Filed by: Ryan Charles S.
Form 4 Quince Therapeutics, For: Jan 23 Filed by: Hannah Brendan
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.